Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design. Dhaka Univ. J. Pharm. Sci. 2024;23(2):135-143. doi:10.3329/dujps.v23i2.78571